Need professional-grade analysis? Visit stockanalysis.com
$11.85B
487.00
470
N/A
Chengdu Olymvax Biopharmaceuticals Inc. A (688319) trades on SHG in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY29.82, up 2.40% from the previous close.
Over the past year, 688319 has traded between a low of CNY15.00 and a high of CNY33.17. The stock has gained 89.9% over this period. It is currently 10.1% below its 52-week high.
Chengdu Olymvax Biopharmaceuticals Inc. A has a market capitalization of $11.85B, with a price-to-earnings ratio of 487.00.
Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sales of vaccines for human use in China. The company offers absorbed tetanus vaccine, group a and group c products; and haemophilus influenzae type b. It also provides Hib conjugate vaccine and AC conjugate vaccine; and group A and C meningococcal polysaccharide conjugate vaccine. The company was founded in 2009 and is based in Chengdu, China.
Side-by-side comparison against top Healthcare peers.